Title Chinese guidelines on the management of ascites and its related complications in cirrhosis
Authors Xu, Xiaoyuan
Duan, Zhongping
Ding, Huiguo
Li, Wengang
Jia, Jidong
Wei, Lai
Linghu, Enqiang
Zhuang, Hui
Affiliation Peking Univ, Dept Infect Dis, Hosp 1, Beijing 100034, Peoples R China
Capital Med Univ, Beijing You An Hosp, Artificial Liver Ctr, Beijing 100069, Peoples R China
Capital Med Univ, Beijing You An Hosp, Ctr Hepatol & Gastroenterol, Beijing, Peoples R China
302 Mil Hosp China, Liver Tumor Diag Treatment & Res Ctr, Beijing, Peoples R China
Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing, Peoples R China
Peking Univ, Peoples Hosp, Inst Hepatol, Beijing, Peoples R China
Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol, Beijing, Peoples R China
Peking Univ, Dept Pathogen Biol, Hlth Sci Ctr, Beijing, Peoples R China
Keywords Liver cirrhosis
Ascites
SBP
Hepatorenal syndrome
Diagnosis
Therapy
Guidelines
Issue Date 2019
Publisher HEPATOLOGY INTERNATIONAL
Abstract The Chinese Society of Hepatology developed the current guidelines for the Management of Ascites and Its Related Complications in Cirrhosis based on the published evidences and the panelists' consensus. The guidelines provided recommendations for the diagnosis and management of cirrhotic ascites emphasizing a step-wise approach with the first-, second-, and third-line therapy. For refractory ascites, vasoconstrictors and albumin are recommended for splanchnic vasodilation and selective vasopressin (V2) receptor antagonists for moderate-to-severe hyponatremia. For spontaneous bacterial peritonitis, empirical anti-infection treatment was recommended based on the local microbiological examination of community- or hospital-acquired infections. For hepatorenal syndrome, the administration of vasopressor terlipressin and albumin is recommended.
URI http://hdl.handle.net/20.500.11897/552152
ISSN 1936-0533
DOI 10.1007/s12072-018-09923-2
Indexed SCI(E)
Appears in Collections: 第一医院
人民医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.